Skip to main content
SpringerLink
Log in

Sensitive Cardiac Troponins: Could They Be New Biomarkers in Pediatric Pulmonary Hypertension Due to Congenital Heart Disease?

  • Original Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

To analyze the role of sensitive cardiac troponin I (scTnI) and high-sensitive troponin T (hscTnT) in the determination of myocardial injury caused by volume and pressure load due to pulmonary hypertension (PH) and to investigate if these markers may be useful in the management of PH in childhood. Twenty-eight patients with congenital heart disease (CHD) with left to right shunt and PH, 29 patients with CHD with left to right shunt but without PH, and 18 healthy children, in total 75 individuals, were included in the study. All cases were aged between 4 and 36 months. Echocardiographic evaluation was performed in all cases, and invasive hemodynamic investigation was performed in 33 cases. Blood samples were obtained from all cases, for the measurement of brain natriuretic peptide (BNP), pro-brain natriuretic peptide (pro-BNP), sensitive cardiac troponin I (scTnI), and high-sensitive troponin T (hscTnT) levels. The mean BNP, pro-BNP, scTnI, and hsTnT levels were statistically significantly higher in patients with PH than in the patients without PH (p < 0.001). A statistically significant positive correlation was determined between pulmonary artery systolic pressure and scTnI and hscTnT levels (r = 0.34 p = 0.01, r = 0.46 p < 0.001, respectively) levels. Pulmonary hypertension determined in congenital heart diseases triggers myocardial damage independently of increased volume or pressure load and resistance, occurring by disrupting the perfusion via increasing ventricular wall tension and the myocardial oxygen requirement. Serum scTnI and hscTnT levels may be helpful markers to determine the damage associated with PH in childhood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Olguntürk R (2010) Pediatric pulmonary hypertension and pulmonary arterial hypertension secondary to congenital heart diseases. Anadol Kardiyol Derg 10:50–56

    Article  Google Scholar 

  2. Lammers AE, Apitz C, Zartner P, Hager A, Dubowy KO, Hansmann G (2016) Diagnostics, monitoring and outpatient care in children with suspected pulmonary hypertension/paediatric pulmonary hypertensive vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart 102:1–13

    Article  Google Scholar 

  3. Haworth SG (2006) The management of children with congenital heart disease. Pulmonary Arterial Hypertension Related to Congenital Heart Disease 1st ed. London

  4. Joshi R, Kalra R, Kumar N, Aggarwal N (2016) Critical decision of operability in congenital heart disease patient with severe pulmonary hypertension. Ann Card Anaesth 19:744

    Article  PubMed  PubMed Central  Google Scholar 

  5. Apitz C, Hansmann G, Schranz D (2016) Hemodynamic assessment and acute pulmonary vasoreactivity testing in the evaluation of children with pulmonary vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart 102:23–29

    Article  Google Scholar 

  6. Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jais X, Marinelli A (2006) Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 48:2546–2552

    Article  PubMed  Google Scholar 

  7. Pattathu J, Gorenflo M, Hilgendorff A, Koskenvuo JW, Apitz C, Hansmann G, Alastalo TP (2016) Genetic testing and blood biomarkers in paediatric pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart 102:36–41

    Article  Google Scholar 

  8. Pezzuto B, Badagliacca R, Poscia R, Ghio S, D’Alto M, Vitulo P, Mulè M, Albera C, Volterrani M, Fedele F, Vizza CD (2015 Mar) Circulating biomarkers in pulmonary arterial hypertension: update and future direction. J Heart Lung Transplant 34:282–305

    Article  PubMed  Google Scholar 

  9. Yilmaz MB, Zorlu A, Dogan OT, Karahan O, Tandogan I, Akkurt I (2011) Role of CA-125 in identification of right ventricular failure in chronic obstructive pulmonary disease. Clin Cardiol 34:244–248

    Article  PubMed  Google Scholar 

  10. Oguz MM, Oguz AD, Sanli C, Cevik A (2014) Serum levels of soluble ICAM-1 in children with pulmonary artery hypertension. Tex Heart Inst J 4:159–164

    Article  Google Scholar 

  11. Yıldırım A, Güzelmeriç F, Öner CN, Karaağaç AT, Şaşmazel A, Erdem H, Özdemir O, Baysal A (2014) Prognostic significance of sICAM-1 and sVCAM-1 molecules for cardiac surgery in pediatric patients with pulmonary hypertension. Anadolu Kardiyol Derg 14:274–279

    PubMed  Google Scholar 

  12. Garg P, Morris P, Fazlanie AL, Vijayan S, Dancso B, Dastidar AG, Plein S, Mueller C, Haaf P (2017) Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Intern Emerg Med 12:147–155

    Article  PubMed  PubMed Central  Google Scholar 

  13. Hafez MO, Morsy SM, Mahfoz RA, Ali AR (2015) Myocardial injury in children with unoperated congenital heart diseases. Cardiol Res Pract. https://doi.org/10.1155/2015/104818

    PubMed  PubMed Central  Google Scholar 

  14. Torbicki A, Kurzyna M, Kuca P, Fijałkowska A, Sikora J, Florczyk M et al (2003) Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 108:844–848

    Article  CAS  PubMed  Google Scholar 

  15. Antman EM (2002) Decision making with cardiac troponin tests. N Engl J Med 346:2079–2082

    Article  PubMed  Google Scholar 

  16. Mair J (2014) High-sensitivity cardiac troponins in everyday clinical practice. World J Cardiol 6:175–182

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kunii Y, Kamada M, Ohtsuki S, Araki T, Kataoka K, Kageyama M et al (2003) Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 57(4):191–197

    CAS  PubMed  Google Scholar 

  18. Bader D, Kugelman A, Lanir A, Tamir A, Mula E, Riskin A (2006) Cardiac troponin I serum concentrations in newborns: a study and review of literature. Clin Chin Acta 371(1–2):61–65

    Article  CAS  Google Scholar 

  19. Bossone E, D’Andrea A, D’Alto M, Citro R, Argiento P, Ferrara F et al (2013) Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. J Am Soc Echocardiogr 26:1–14

    Article  PubMed  Google Scholar 

  20. Apple FS, Wu AHB, Jaffe AS (2002) European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 144:981–986

    Article  PubMed  Google Scholar 

  21. Apple FS, Wu AHB (2001) Myocardial infarction redefined: role of cardiac troponin testing. Clin Chem 47:377–379

    CAS  PubMed  Google Scholar 

  22. Antman EM, Tanasijevic MJ, Thompson B et al (1996) Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Eng J Med 335:1342–1349

    Article  CAS  Google Scholar 

  23. Venge P, Langerquist B, Diderholm E et al (2002) On behalf of the FRISC II Study Group. Clinical Performance of three cardiac troponin assays in patients with unstable coronary artery disease (FRISC II substudy). Am J Cardiol 89:1035–1041

    Article  CAS  PubMed  Google Scholar 

  24. Özhan H, Albayrak S, Uzun H,et al (2007) Correlation of plasma B Type natriuretic peptide with shunt severity in patients with atrial or ventricular septal defect. Pediatr Cardiol 28:272–275

    Article  PubMed  Google Scholar 

  25. Holmström H, Hall C, Thaulow E (2001) Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr 90:184–191

    Article  PubMed  Google Scholar 

  26. Leuchte HH, Holzapfel M, Baumgartner RA et al (2005) Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension. Chest 128:2368–2374

    Article  CAS  PubMed  Google Scholar 

  27. Fijalkowska A, Kurzyna M, Torbicki A et al (2006) Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 129:1313–1321

    Article  CAS  PubMed  Google Scholar 

  28. Conen D, Pfisterer M, Martina B (2006) Substantial intraindividual variability of BNP concentrations in patients with hypertension. J Hum Hypertens 20:387–391

    Article  CAS  PubMed  Google Scholar 

  29. Takatsuki S, Wagner BD, Ivy D (2012) B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension. Congenit Heart Dis 7(3):259–267

    Article  PubMed  PubMed Central  Google Scholar 

  30. Bernus A, Wagner BD, Accurso F et al. (2009) Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension. Chest 135(3):745–751

    Article  CAS  PubMed  Google Scholar 

  31. Galie N, Manes A, Palazzini M et al (2008) Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger’s syndrome. Drugs 68:1049–1066

    Article  CAS  PubMed  Google Scholar 

  32. Kubo T, Kitaoka H, Okawa M et al (2010) Serum cardiac troponin I is related to increased left ventricular wall thickness, left ventricular dysfunction, and male gender in hypertrophic cardiomyopathy. Clin Cardiol 33:E1–E7

    Article  PubMed  Google Scholar 

  33. Petersen SE, Jerosch-Herold M, Hudsmith LE et al (2007) Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 115:2418–2425

    Article  PubMed  Google Scholar 

  34. Galderisi M (2007) Epicardial coronary vessels and coronary microcirculation in pressure overload hypertrophy: a complex interaction. Am J Hypertens 20:285–286.

    Article  PubMed  Google Scholar 

  35. Apple FS (2009) A new season for cardiac troponin assays: it’s time to keep a scorecard. Clin Chem 55:7 1303–1306

    PubMed  Google Scholar 

  36. Xu RY, Zhu XF, Yang Y, Ye P (2013) High-sensitive cardiac troponin T. J Geriatr Cardiol 10:102–109

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Colvin KL, Dufva MJ, Delaney RP, Ivy DD, Stenmark KR, Yeager M (2014) Biomarkers for pediatric pulmonary arterial hypertension—a call to collaborate. Front Pediatr 2:1–12

    Article  Google Scholar 

  38. Zelniker T, Uhlmann L, Spaich S, Friedrich J, Preusch MR, Meyer FJ et al. (2015) Novel biomarkers for risk stratification in pulmonary arterial hypertension. ERJ Open Res 1:00008-2015

    Article  PubMed  PubMed Central  Google Scholar 

  39. Eggers KM, Lindahl B (2017) Application of cardiac troponin in cardiovascular diseases other than acute coronary syndrome. Clin Chem 63:223–235

    Article  CAS  PubMed  Google Scholar 

  40. Sugimoto M, Ota K, Kajihama A, Nakau K et al (2011) Volume overload and pressure overload due to left-to-right shunt- induced myocardial injury: evaluation using a highly sensitive cardiac troponin I assay in children with congenital heart disease. Circ J 75:2213–2219

    Article  CAS  PubMed  Google Scholar 

  41. Eerola A, Jokinen EO, Savukoski TI et al (2013) Cardiac troponin I in congenital heart defects with pressure or volume overload. Scand Cardiovasc J 47:154–159

    Article  CAS  PubMed  Google Scholar 

  42. Filusch A, Giannitsis E, Katus HA, Meyer FJ (2010) High-sensitive troponin T: a novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertension. Clin Sci 119:207–213

    Article  CAS  PubMed  Google Scholar 

  43. Apple FS (1999) Clinical and analytical standardization ıssues confronting cardiac troponin I. Clin Chem 45(1):18–20

    CAS  PubMed  Google Scholar 

  44. Labugger R, Organ L, Collier C et al (2000) Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 102:1221–1226

    Article  CAS  PubMed  Google Scholar 

  45. Tate JR, Heathcote D, Rayfield J, Hickman PE (1999) The lack of standardization of cardiac troponin I assay systems. Clin Chim Acta 284:141–149

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Cardiology Department, Keçiören Training and Research Hospital, Pınarbasi Mahallesi, Sanatoryum Caddesi, Ardahan Sokak 06380 No:25, Keçiören/Ankara, Turkey

    Seyma Kayali

  2. Pediatric Cardiology Department, Medical Faculty, Hacettepe Univercity, Ankara, Turkey

    Ilker Ertugrul

  3. Pediatric Cardiology Department, Dr. Sami Ulus Maternity and Children Training and Research Hospital, Ankara, Turkey

    Tamer Yoldas, Ozkan Kaya, Senem Ozgür, Utku A. Orün & Selmin Karademir

Authors
  1. Seyma Kayali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ilker Ertugrul
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tamer Yoldas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ozkan Kaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Senem Ozgür
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Utku A. Orün
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Selmin Karademir
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seyma Kayali.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kayali, S., Ertugrul, I., Yoldas, T. et al. Sensitive Cardiac Troponins: Could They Be New Biomarkers in Pediatric Pulmonary Hypertension Due to Congenital Heart Disease?. Pediatr Cardiol 39, 718–725 (2018). https://doi.org/10.1007/s00246-018-1811-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-018-1811-1

Keywords

Search

Navigation